Albert Rivera, DO
MOHS-Micrographic Surgery · Madison, ALNPI 1366583882
Payments from drug & device makers
What this record shows
26 manufacturers reported payments, led by AbbVie at 59.9% of the total. Reporting peaked in 2021 at $3,345 and has fallen 76.1% since, to $799 in 2025.
Across 121 payments — averaging $51.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Novartis$572
- Solta Medical, A Division Of Bausch Health US, LLC$514
- Sanofi$215
- Kerecis Limited$169
- Pfizer$129
- plus $887 from 20 others
What the payments were for
- Speaking & faculty fees$3,33354%
- Food & beverage$2,86746%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $3,714 |
| Novartis | 36 | $572 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $514 |
| Sanofi | 6 | $215 |
| Kerecis Limited | 3 | $169 |
| Pfizer | 9 | $129 |
| Johnson & Johnson | 6 | $113 |
| Amgen | 5 | $104 |
| Sun Pharmaceutical Industries Inc. | 4 | $76 |
| LEO Pharma Inc. | 3 | $65 |
| UCB, Inc. | 2 | $58 |
| Lilly USA, LLC | 3 | $57 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Organogenesis Inc. | 3 | $54 |
| Dermira, Inc. | 2 | $51 |
| Biofrontera Inc. | 2 | $39 |
| Almirall LLC | 2 | $38 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $28 |
| Dermavant Sciences, Inc. | 2 | $26 |
| Incyte Corporation | 1 | $23 |
| Convatec Inc. | 1 | $20 |
| DUSA Pharmaceuticals, Inc. | 1 | $20 |
| Galderma Laboratories, L.p. | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $12 |
How this compares
Too few mohs-micrographic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 29 | $2,615 |
| Doxycycline Hyclate | 15 | $106 |
| Cephalexin | 19 | $26 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Madison
- Vernon ForresterMadison$4K
- Gary MonheitBirmingham$37K
- Jeffrey StrickerDothan$10K
- Adam RichardsonNorthport$8K
- Michael HadleyBirmingham$3K
- Scott FreemanMobile$3K
- Bailey TayebiBirmingham$3K
- Conway HuangBirmingham$3K
- Raj PatelAlabaster$2K
- Michael FranzettiBirmingham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.